Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 643

1.

Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response.

Uribe-Herranz M, Rafail S, Beghi S, Gil-de-Gómez L, Verginadis I, Bittinger K, Pustylnikov S, Pierini S, Perales-Linares R, Blair IA, Mesaros CA, Snyder NW, Bushman F, Koumenis C, Facciabene A.

J Clin Invest. 2019 Dec 9. pii: 124332. doi: 10.1172/JCI124332. [Epub ahead of print]

2.

Amyotrophic lateral sclerosis-linked UBQLN2 mutants inhibit endoplasmic reticulum to Golgi transport, leading to Golgi fragmentation and ER stress.

Halloran M, Ragagnin AMG, Vidal M, Parakh S, Yang S, Heng B, Grima N, Shahheydari H, Soo KY, Blair I, Guillemin GJ, Sundaramoorthy V, Atkin JD.

Cell Mol Life Sci. 2019 Dec 4. doi: 10.1007/s00018-019-03394-w. [Epub ahead of print]

PMID:
31802140
3.

Cervicovaginal fluid proteomic analysis to identify potential biomarkers for preterm birth.

Parry S, Leite R, Sean Esplin M, Bukowski R, Zhang H, Varner M, Andrews WW, Saade GR, Ilekis J, Reddy UM, Huang H, Sadovsky Y, Blair IA, Biggio J; Eunice Kennedy Shriver National Institute of Child Health and Human Development Genomic and Proteomic Network for Preterm Birth Research.

Am J Obstet Gynecol. 2019 Nov 20. pii: S0002-9378(19)32631-6. doi: 10.1016/j.ajog.2019.11.1252. [Epub ahead of print]

PMID:
31758918
4.

CMS-01 Genetic testing for familial amyotrophic lateral sclerosis (ALS): insights and challenges.

Crook A, Hogden A, Mumford V, Blair IP, Williams KL, Rowe DB.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(sup1):327-347. doi: 10.1080/21678421.2019.1647002.

PMID:
31702461
5.

Theme 3 In vitro experimental models.

Yang S, Wu S, Fifita J, McCann E, Fat SCM, Galper J, Freckleton S, Zhang KY, Blair IP.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(sup1):135-159. doi: 10.1080/21678421.2019.1646991.

PMID:
31702460
6.

Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice.

McCann EP, Fifita JA, Grima N, Galper J, Mehta P, Freckleton SE, Zhang KY, Henden L, Hogan AL, Chan Moi Fat S, Wu SS, Jagaraj CJ, Berning BA, Williams KL, Twine NA, Bauer D, Piguet O, Hodges J, Kwok JBJ, Halliday GM, Kiernan MC, Atkin J, Rowe DB, Nicholson GA, Walker AK, Blair IP, Yang S.

J Neurol Neurosurg Psychiatry. 2019 Nov 5. pii: jnnp-2019-321790. doi: 10.1136/jnnp-2019-321790. [Epub ahead of print]

PMID:
31690696
7.

Correction to "Role of Human Aldo-Keto Reductases in the Metabolic Activation of the Carcinogenic Air Pollutant 3-Nitrobenzanthrone".

Murray JR, Mesaros CA, Arlt VM, Seidel A, Blair IA, Penning TM.

Chem Res Toxicol. 2019 Nov 18;32(11):2365. doi: 10.1021/acs.chemrestox.9b00420. Epub 2019 Oct 30. No abstract available.

PMID:
31663337
8.

Heavy metal content of herbal health supplement products in Dubai - UAE: a cross-sectional study.

Abdulla NM, Adam B, Blair I, Oulhaj A.

BMC Complement Altern Med. 2019 Oct 21;19(1):276. doi: 10.1186/s12906-019-2693-3.

9.

In Vitro Biotransformation of the Nrf2 Activator Bardoxolone: Formation of an Epoxide Metabolite That Undergoes Two Novel Glutathione-Mediated Metabolic Pathways: Epoxide Reduction and Oxidative Elimination of Nitrile Moiety.

Kamel AM, Bowlin S, Anwar B, Reichard H, Argus J, Blair IA.

Chem Res Toxicol. 2019 Nov 18;32(11):2268-2280. doi: 10.1021/acs.chemrestox.9b00289. Epub 2019 Oct 25.

PMID:
31613099
10.

Voriconazole enhances UV-induced DNA damage by inhibiting catalase and promoting oxidative stress.

Lee V, Gober MD, Bashir H, O'Day C, Blair IA, Mesaros C, Weng L, Huang A, Chen A, Tang R, Anagnos V, Li J, Roling S, Sagaityte E, Wang A, Lin C, Yeh C, Atillasoy C, Marshall C, Dentchev T, Ridky T, Seykora JT.

Exp Dermatol. 2019 Sep 13. doi: 10.1111/exd.14038. [Epub ahead of print]

PMID:
31519066
11.

Generation and characterization of a human induced pluripotent stem cell line UOWi005-A from dermal fibroblasts derived from a CCNFS621G familial amyotrophic lateral sclerosis patient using mRNA reprogramming.

Bax M, Balez R, Muñoz SS, Do-Ha D, Stevens CH, Berg T, Cabral-da-Silva MC, Engel M, Nicholson G, Yang S, Blair IP, Ooi L.

Stem Cell Res. 2019 Oct;40:101530. doi: 10.1016/j.scr.2019.101530. Epub 2019 Aug 14.

12.

The proteome and its dynamics: A missing piece for integrative multi-omics in schizophrenia.

Borgmann-Winter KE, Wang K, Bandyopadhyay S, Torshizi AD, Blair IA, Hahn CG.

Schizophr Res. 2019 Aug 12. pii: S0920-9964(19)30303-2. doi: 10.1016/j.schres.2019.07.025. [Epub ahead of print]

PMID:
31416743
13.

Mutaba'ah-Mother and Child Health Study: protocol for a prospective cohort study investigating the maternal and early life determinants of infant, child, adolescent and maternal health in the United Arab Emirates.

Al Haddad A, Ali N, Elbarazi I, Elabadlah H, Al-Maskari F, Narchi H, Brabon C, Ghazal-Aswad S, AlShalabi FM, Zampelas A, Loney T, Blair I, Ahmed LA.

BMJ Open. 2019 Aug 5;9(8):e030937. doi: 10.1136/bmjopen-2019-030937.

14.

Analytical Methods for Mass Spectrometry-Based Metabolomics Studies.

Wang S, Blair IA, Mesaros C.

Adv Exp Med Biol. 2019;1140:635-647. doi: 10.1007/978-3-030-15950-4_38. Review.

PMID:
31347076
15.

Prevalence of, and factors associated with health supplement use in Dubai, United Arab Emirates: a population-based cross-sectional study.

Abdulla NM, Aziz F, Blair I, Grivna M, Adam B, Loney T.

BMC Complement Altern Med. 2019 Jul 12;19(1):172. doi: 10.1186/s12906-019-2593-6.

16.

The current state of biomarker research for Friedreich's ataxia: a report from the 2018 FARA biomarker meeting.

Blair IA, Farmer J, Hersch S, Larkindale J, Lynch DR, Napierala J, Napierala M, Payne RM, Subramony SH.

Future Sci OA. 2019 Jun 28;5(6):FSO398. doi: 10.2144/fsoa-2019-0026. Review.

17.

Evaluation of antibodies for western blot analysis of frataxin protein isoforms.

Weng L, Wang Q, Yu S, Yang X, Lynch DR, Mesaros C, Blair IA.

J Immunol Methods. 2019 Nov;474:112629. doi: 10.1016/j.jim.2019.07.001. Epub 2019 Jul 4.

18.

Prevalence and factors associated with infectious intestinal diseases in Ras Al Khaimah, United Arab Emirates, 2017: A population-based cross-sectional study.

Al Alkeem F, Loney T, Aziz F, Blair I, Sonnevend Á, Sheek-Hussein M.

Int J Infect Dis. 2019 Aug;85:188-194. doi: 10.1016/j.ijid.2019.06.004. Epub 2019 Jun 13.

19.

Monozygotic twins and triplets discordant for amyotrophic lateral sclerosis display differential methylation and gene expression.

Tarr IS, McCann EP, Benyamin B, Peters TJ, Twine NA, Zhang KY, Zhao Q, Zhang ZH, Rowe DB, Nicholson GA, Bauer D, Clark SJ, Blair IP, Williams KL.

Sci Rep. 2019 Jun 4;9(1):8254. doi: 10.1038/s41598-019-44765-4.

20.

The metastability of the proteome of spinal motor neurons underlies their selective vulnerability in ALS.

Yerbury JJ, Ooi L, Blair IP, Ciryam P, Dobson CM, Vendruscolo M.

Neurosci Lett. 2019 Jun 21;704:89-94. doi: 10.1016/j.neulet.2019.04.001. Epub 2019 Apr 3.

PMID:
30953736
21.

Using Values Affirmation to Reduce the Effects of Stereotype Threat on Hypertension Disparities: Protocol for the Multicenter Randomized Hypertension and Values (HYVALUE) Trial.

Daugherty SL, Vupputuri S, Hanratty R, Steiner JF, Maertens JA, Blair IV, Dickinson LM, Helmkamp L, Havranek EP.

JMIR Res Protoc. 2019 Mar 25;8(3):e12498. doi: 10.2196/12498.

22.

The C9orf72 hexanucleotide repeat expansion presents a challenge for testing laboratories and genetic counseling.

Crook A, McEwen A, Fifita JA, Zhang K, Kwok JB, Halliday G, Blair IP, Rowe DB.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):310-316. doi: 10.1080/21678421.2019.1588904. Epub 2019 Mar 23.

PMID:
30907153
23.

Metabolic Detection of Bruton's Tyrosine Kinase Inhibition in Mantle Cell Lymphoma Cells.

Lee SC, Shestov AA, Guo L, Zhang Q, Roman JC, Liu X, Wang HY, Pickup S, Nath K, Lu P, Hofbauer S, Mesaros C, Wang YL, Nelson DS, Schuster SJ, Blair IA, Glickson JD, Wasik MA.

Mol Cancer Res. 2019 Jun;17(6):1365-1377. doi: 10.1158/1541-7786.MCR-18-0256. Epub 2019 Mar 12.

PMID:
30862686
24.

Correction to Liquid Chromatography-High Resolution Mass Spectrometry Analysis of Platelet Frataxin as a Protein Biomarker for the Rare Disease Friedreich's Ataxia.

Guo L, Wang Q, Weng L, Hauser LA, Strawser CJ, Rocha AG, Dancis A, Mesaros C, Lynch DR, Blair IA.

Anal Chem. 2019 Feb 5;91(3):2560. doi: 10.1021/acs.analchem.9b00141. Epub 2019 Jan 24. No abstract available.

PMID:
30676739
25.

Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia.

Lynch DR, Farmer J, Hauser L, Blair IA, Wang QQ, Mesaros C, Snyder N, Boesch S, Chin M, Delatycki MB, Giunti P, Goldsberry A, Hoyle C, McBride MG, Nachbauer W, O'Grady M, Perlman S, Subramony SH, Wilmot GR, Zesiewicz T, Meyer C.

Ann Clin Transl Neurol. 2018 Nov 10;6(1):15-26. doi: 10.1002/acn3.660. eCollection 2019 Jan.

26.

Characterization of a new N-terminally acetylated extra-mitochondrial isoform of frataxin in human erythrocytes.

Guo L, Wang Q, Weng L, Hauser LA, Strawser CJ, Mesaros C, Lynch DR, Blair IA.

Sci Rep. 2018 Nov 19;8(1):17043. doi: 10.1038/s41598-018-35346-y.

27.

Role of Human Aldo-Keto Reductases in the Metabolic Activation of the Carcinogenic Air Pollutant 3-Nitrobenzanthrone.

Murray JR, Mesaros CA, Arlt VM, Seidel A, Blair IA, Penning TM.

Chem Res Toxicol. 2018 Nov 19;31(11):1277-1288. doi: 10.1021/acs.chemrestox.8b00250. Epub 2018 Nov 8. Erratum in: Chem Res Toxicol. 2019 Nov 18;32(11):2365.

28.

Expression of ALS/FTD-linked mutant CCNF in zebrafish leads to increased cell death in the spinal cord and an aberrant motor phenotype.

Hogan AL, Don EK, Rayner SL, Lee A, Laird AS, Watchon M, Winnick C, Tarr IS, Morsch M, Fifita JA, Gwee SSL, Formella I, Hortle E, Yuan KC, Molloy MP, Williams KL, Nicholson GA, Chung RS, Blair IP, Cole NJ.

Hum Mol Genet. 2019 Feb 15;28(4):698. doi: 10.1093/hmg/ddy362. No abstract available.

PMID:
30371781
29.

Motor Neuron Abnormalities Correlate with Impaired Movement in Zebrafish that Express Mutant Superoxide Dismutase 1.

Robinson KJ, Yuan KC, Don EK, Hogan AL, Winnick CG, Tym MC, Lucas CW, Shahheydari H, Watchon M, Blair IP, Atkin JD, Nicholson GA, Cole NJ, Laird AS.

Zebrafish. 2019 Feb;16(1):8-14. doi: 10.1089/zeb.2018.1588. Epub 2018 Oct 27.

30.

Impact of route of administration on genotoxic oestrogens concentrations using oral vs transdermal oestradiol in girls with Turner syndrome.

Mauras N, Torres-Santiago L, Santen R, Mericq V, Ross J, Colon-Otero G, Damaso L, Hossain J, Wang Q, Mesaros C, Blair IA.

Clin Endocrinol (Oxf). 2019 Jan;90(1):155-161. doi: 10.1111/cen.13869. Epub 2018 Oct 25.

PMID:
30281805
31.

Effect of Differences in Metabolic Activity of Melanoma Models on Response to Lonidamine plus Doxorubicin.

Nath K, Roman J, Nelson DS, Guo L, Lee SC, Orlovskiy S, Muriuki K, Heitjan DF, Pickup S, Leeper DB, Blair IA, Putt ME, Glickson JD.

Sci Rep. 2018 Oct 2;8(1):14654. doi: 10.1038/s41598-018-33019-4.

32.

Gestational Diabetes Alters the Metabolomic Profile in 2nd Trimester Amniotic Fluid in a Sex-Specific Manner.

O'Neill K, Alexander J, Azuma R, Xiao R, Snyder NW, Mesaros CA, Blair IA, Pinney SE.

Int J Mol Sci. 2018 Sep 10;19(9). pii: E2696. doi: 10.3390/ijms19092696.

33.

Neuronal cell culture from transgenic zebrafish models of neurodegenerative disease.

Acosta JR, Watchon M, Yuan KC, Fifita JA, Svahn AJ, Don EK, Winnick CG, Blair IP, Nicholson GA, Cole NJ, Goldsbury C, Laird AS.

Biol Open. 2018 Oct 16;7(10). pii: bio036475. doi: 10.1242/bio.036475.

34.

Temporal Trends in Contemporary Use of Ventricular Assist Devices by Race and Ethnicity.

Breathett K, Allen LA, Helmkamp L, Colborn K, Daugherty SL, Blair IV, Jones J, Khazanie P, Mazimba S, McEwen M, Stone J, Calhoun E, Sweitzer NK, Peterson PN.

Circ Heart Fail. 2018 Aug;11(8):e005008. doi: 10.1161/CIRCHEARTFAILURE.118.005008.

35.

Quantification of Serum High Mobility Group Box 1 by Liquid Chromatography/High-Resolution Mass Spectrometry: Implications for Its Role in Immunity, Inflammation, and Cancer.

Weng L, Guo L, Vachani A, Mesaros C, Blair IA.

Anal Chem. 2018 Jun 19;90(12):7552-7560. doi: 10.1021/acs.analchem.8b01175. Epub 2018 Jun 5.

36.

Arginase 2 Suppresses Renal Carcinoma Progression via Biosynthetic Cofactor Pyridoxal Phosphate Depletion and Increased Polyamine Toxicity.

Ochocki JD, Khare S, Hess M, Ackerman D, Qiu B, Daisak JI, Worth AJ, Lin N, Lee P, Xie H, Li B, Wubbenhorst B, Maguire TG, Nathanson KL, Alwine JC, Blair IA, Nissim I, Keith B, Simon MC.

Cell Metab. 2018 Jun 5;27(6):1263-1280.e6. doi: 10.1016/j.cmet.2018.04.009. Epub 2018 May 10.

37.

African Americans Are Less Likely to Receive Care by a Cardiologist During an Intensive Care Unit Admission for Heart Failure.

Breathett K, Liu WG, Allen LA, Daugherty SL, Blair IV, Jones J, Grunwald GK, Moss M, Kiser TH, Burnham E, Vandivier RW, Clark BJ, Lewis EF, Mazimba S, Battaglia C, Ho PM, Peterson PN.

JACC Heart Fail. 2018 May;6(5):413-420. doi: 10.1016/j.jchf.2018.02.015. Erratum in: JACC Heart Fail. 2018 Jul;6(7):617.

38.

Bioorthogonal pro-metabolites for profiling short chain fatty acylation.

Sinclair WR, Shrimp JH, Zengeya TT, Kulkarni RA, Garlick JM, Luecke H, Worth AJ, Blair IA, Snyder NW, Meier JL.

Chem Sci. 2017 Dec 8;9(5):1236-1241. doi: 10.1039/c7sc00247e. eCollection 2018 Feb 7.

39.

The CPT1a inhibitor, etomoxir induces severe oxidative stress at commonly used concentrations.

O'Connor RS, Guo L, Ghassemi S, Snyder NW, Worth AJ, Weng L, Kam Y, Philipson B, Trefely S, Nunez-Cruz S, Blair IA, June CH, Milone MC.

Sci Rep. 2018 Apr 19;8(1):6289. doi: 10.1038/s41598-018-24676-6.

40.

Differential Reliance on Lipid Metabolism as a Salvage Pathway Underlies Functional Differences of T Cell Subsets in Poor Nutrient Environments.

Ecker C, Guo L, Voicu S, Gil-de-Gómez L, Medvec A, Cortina L, Pajda J, Andolina M, Torres-Castillo M, Donato JL, Mansour S, Zynda ER, Lin PY, Varela-Rohena A, Blair IA, Riley JL.

Cell Rep. 2018 Apr 17;23(3):741-755. doi: 10.1016/j.celrep.2018.03.084.

41.

Microbes vs. chemistry in the origin of the anaerobic gut lumen.

Friedman ES, Bittinger K, Esipova TV, Hou L, Chau L, Jiang J, Mesaros C, Lund PJ, Liang X, FitzGerald GA, Goulian M, Lee D, Garcia BA, Blair IA, Vinogradov SA, Wu GD.

Proc Natl Acad Sci U S A. 2018 Apr 17;115(16):4170-4175. doi: 10.1073/pnas.1718635115. Epub 2018 Apr 2.

42.

Pediatric Multiple Sclerosis in the United Arab Emirates: Characteristics From a Multicenter Study and Global Comparison.

Ismail FY, Gordon-Lipkin E, Huether K, Blair I, Szólics M, Alsaadi T, Aziz F, Suleiman J, Schiess N.

J Child Neurol. 2018 May;33(6):422-427. doi: 10.1177/0883073818759103. Epub 2018 Apr 1.

PMID:
29607711
43.

Effect of a tissue selective estrogen complex on breast cancer: Role of unique properties of conjugated equine estrogen.

Yue W, Wang J, Atkins KA, Bottalico L, Mesaros C, Blair IA, Santen RJ.

Int J Cancer. 2018 Sep 1;143(5):1259-1268. doi: 10.1002/ijc.31401. Epub 2018 Apr 16.

44.

Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.

Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ, Nalls MA, Keagle P, Rivera AM, van Rheenen W, Murphy NA, van Vugt JJFA, Geiger JT, Van der Spek RA, Pliner HA, Shankaracharya, Smith BN, Marangi G, Topp SD, Abramzon Y, Gkazi AS, Eicher JD, Kenna A; ITALSGEN Consortium, Mora G, Calvo A, Mazzini L, Riva N, Mandrioli J, Caponnetto C, Battistini S, Volanti P, La Bella V, Conforti FL, Borghero G, Messina S, Simone IL, Trojsi F, Salvi F, Logullo FO, D'Alfonso S, Corrado L, Capasso M, Ferrucci L; Genomic Translation for ALS Care (GTAC) Consortium, Moreno CAM, Kamalakaran S, Goldstein DB; ALS Sequencing Consortium, Gitler AD, Harris T, Myers RM; NYGC ALS Consortium, Phatnani H, Musunuri RL, Evani US, Abhyankar A, Zody MC; Answer ALS Foundation, Kaye J, Finkbeiner S, Wyman SK, LeNail A, Lima L, Fraenkel E, Svendsen CN, Thompson LM, Van Eyk JE, Berry JD, Miller TM, Kolb SJ, Cudkowicz M, Baxi E; Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium, Benatar M, Taylor JP, Rampersaud E, Wu G, Wuu J; SLAGEN Consortium, Lauria G, Verde F, Fogh I, Tiloca C, Comi GP, Sorarù G, Cereda C; French ALS Consortium, Corcia P, Laaksovirta H, Myllykangas L, Jansson L, Valori M, Ealing J, Hamdalla H, Rollinson S, Pickering-Brown S, Orrell RW, Sidle KC, Malaspina A, Hardy J, Singleton AB, Johnson JO, Arepalli S, Sapp PC, McKenna-Yasek D, Polak M, Asress S, Al-Sarraj S, King A, Troakes C, Vance C, de Belleroche J, Baas F, Ten Asbroek ALMA, Muñoz-Blanco JL, Hernandez DG, Ding J, Gibbs JR, Scholz SW, Floeter MK, Campbell RH, Landi F, Bowser R, Pulst SM, Ravits JM, MacGowan DJL, Kirby J, Pioro EP, Pamphlett R, Broach J, Gerhard G, Dunckley TL, Brady CB, Kowall NW, Troncoso JC, Le Ber I, Mouzat K, Lumbroso S, Heiman-Patterson TD, Kamel F, Van Den Bosch L, Baloh RH, Strom TM, Meitinger T, Shatunov A, Van Eijk KR, de Carvalho M, Kooyman M, Middelkoop B, Moisse M, McLaughlin RL, Van Es MA, Weber M, Boylan KB, Van Blitterswijk M, Rademakers R, Morrison KE, Basak AN, Mora JS, Drory VE, Shaw PJ, Turner MR, Talbot K, Hardiman O, Williams KL, Fifita JA, Nicholson GA, Blair IP, Rouleau GA, Esteban-Pérez J, García-Redondo A, Al-Chalabi A; Project MinE ALS Sequencing Consortium, Rogaeva E, Zinman L, Ostrow LW, Maragakis NJ, Rothstein JD, Simmons Z, Cooper-Knock J, Brice A, Goutman SA, Feldman EL, Gibson SB, Taroni F, Ratti A, Gellera C, Van Damme P, Robberecht W, Fratta P, Sabatelli M, Lunetta C, Ludolph AC, Andersen PM, Weishaupt JH, Camu W, Trojanowski JQ, Van Deerlin VM, Brown RH Jr, van den Berg LH, Veldink JH, Harms MB, Glass JD, Stone DJ, Tienari P, Silani V, Chiò A, Shaw CE, Traynor BJ, Landers JE.

Neuron. 2018 Mar 21;97(6):1268-1283.e6. doi: 10.1016/j.neuron.2018.02.027.

45.

Factors Related to Physician Clinical Decision-Making for African-American and Hispanic Patients: a Qualitative Meta-Synthesis.

Breathett K, Jones J, Lum HD, Koonkongsatian D, Jones CD, Sanghvi U, Hoffecker L, McEwen M, Daugherty SL, Blair IV, Calhoun E, de Groot E, Sweitzer NK, Peterson PN.

J Racial Ethn Health Disparities. 2018 Dec;5(6):1215-1229. doi: 10.1007/s40615-018-0468-z. Epub 2018 Mar 5.

46.

Low apolipoprotein A-I levels in Friedreich's ataxia and in frataxin-deficient cells: Implications for therapy.

Wang Q, Guo L, Strawser CJ, Hauser LA, Hwang WT, Snyder NW, Lynch DR, Mesaros C, Blair IA.

PLoS One. 2018 Feb 15;13(2):e0192779. doi: 10.1371/journal.pone.0192779. eCollection 2018.

47.

ERp57 is protective against mutant SOD1-induced cellular pathology in amyotrophic lateral sclerosis.

Parakh S, Jagaraj CJ, Vidal M, Ragagnin AMG, Perri ER, Konopka A, Toth RP, Galper J, Blair IP, Thomas CJ, Walker AK, Yang S, Spencer DM, Atkin JD.

Hum Mol Genet. 2018 Apr 15;27(8):1311-1331. doi: 10.1093/hmg/ddy041.

PMID:
29409023
48.

Analysis of HETEs in human whole blood by chiral UHPLC-ECAPCI/HRMS.

Mazaleuskaya LL, Salamatipour A, Sarantopoulou D, Weng L, FitzGerald GA, Blair IA, Mesaros C.

J Lipid Res. 2018 Mar;59(3):564-575. doi: 10.1194/jlr.D081414. Epub 2018 Jan 4.

49.

Tracking the Implementation of Electronic Medical Records in Dubai, United Arab Emirates, Using an Adoption Benchmarking Tool.

El-Hassan O, Sharif A, Al Redha M, Blair I.

Stud Health Technol Inform. 2017;245:64-68.

PMID:
29295053
50.

Liquid Chromatography-High Resolution Mass Spectrometry Analysis of Platelet Frataxin as a Protein Biomarker for the Rare Disease Friedreich's Ataxia.

Guo L, Wang Q, Weng L, Hauser LA, Strawser CJ, Rocha AG, Dancis A, Mesaros C, Lynch DR, Blair IA.

Anal Chem. 2018 Feb 6;90(3):2216-2223. doi: 10.1021/acs.analchem.7b04590. Epub 2018 Jan 11. Erratum in: Anal Chem. 2019 Feb 5;91(3):2560.

Supplemental Content

Support Center